Clinical Trial Detail

NCT ID NCT01876784
Title Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors AstraZeneca
Indications

thyroid gland cancer

Therapies

Vandetanib

Age Groups: adult

No variant requirements are available.